Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

[News]

Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2013-2014 season. Novartis plans to ship a minimum of 30 million doses of its influenza vaccines to the US market, including Fluvirin (Influenza Virus Vaccine), approved for use in people 4 years of age and older, and Flucelvax (Influenza Virus Vaccine), approved for use in adults 18 years of age and older.

More... (http://www.news-medical.net/news/20130822/Novartis-starts-shipment-of-2013-2014-seasonal-influenza-vaccines-to-US-customers.aspx)